These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1260784)

  • 1. Phase II study of methyl-CCNU (NSC-95441) in advanced gastrointestinal cancer.
    Engstrom PF; Catalano RB; Creech RH
    Cancer Treat Rep; 1976 Mar; 60(3):285-7. PubMed ID: 1260784
    [No Abstract]   [Full Text] [Related]  

  • 2. Methyl-CCNU (NSC-95441) in advanced colorectal carcinoma after failure of 5-fluorouracil (NSC-19893) therapy.
    Cedermark BJ; Didolkar MS; Elias EG
    Cancer Treat Rep; 1976 Mar; 60(3):235-8. PubMed ID: 769977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of methyl-CCNU in the treatment of advanced pancreatic carcinoma.
    Moertel CG; Douglass HO; Hanley J; Carbone PP
    Cancer Treat Rep; 1976 Nov; 60(11):1659-61. PubMed ID: 1035508
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II trial with bleomycin, CCNU, and streptozotocin in patients with metastatic cancer of the breast.
    Band PR; Canellos GP; Sears M; Israel L; Pocock SJ
    Cancer Treat Rep; 1977 Oct; 61(7):1365-7. PubMed ID: 73416
    [No Abstract]   [Full Text] [Related]  

  • 5. Randomized prospective trial comparing 5-fluorouracil (NSC-19893) to 5-fluorouracil and methyl-CCNU (NSC-95441) in advanced gastrointestinal cancer.
    Baker LH; Vaitkevicius VK; Gehan E
    Cancer Treat Rep; 1976 Jun; 60(6):733-7. PubMed ID: 954013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary report on the use of CCNU (NSC-79037), adriamycin (NSC-123127), and hexamethylmelamine (NSC-13875) in carcinoma of the lung.
    Wilson WL; Andrews NC; Frelick RW; Nealon TF; Bick RL; Adams T
    Cancer Treat Rep; 1976 Mar; 60(3):269-71. PubMed ID: 816467
    [No Abstract]   [Full Text] [Related]  

  • 7. A controlled study of 5-fluorouracil versus 5-fluorouracil and methyl-CCNU in advanced gastrointestinal adenocarcinoma.
    Abdallah AM; Soukop M; Bell G; Calman KC
    Clin Oncol; 1977 Sep; 3(3):247-57. PubMed ID: 334430
    [No Abstract]   [Full Text] [Related]  

  • 8. Nitrosoureas: useful agents for the treatment of advanced gastrointestinal cancer.
    Douglass HO; Lavin PT; Moertel CG
    Cancer Treat Rep; 1976 Jun; 60(6):769-80. PubMed ID: 782699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC79037) in the palliative management of advanced gastrointestinal cancer.
    Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
    Cancer Res; 1972 Jun; 32(6):1278-9. PubMed ID: 4113144
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination chemotherapy with methyl-CCNU, 5-fluorouracil, and vincristine in adenocarcinoma and large cell carcinoma of the lung.
    Bernath AM; Cohen MH; Ihde DC; Fossieck BE; Matthews MJ; Minna JD
    Cancer Treat Rep; 1976 Sep; 60(9):1393-4. PubMed ID: 189924
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemotherapy for mustard-resistant ovarian adenocarcinoma: a randomized trial for CCNU and methyl-CCNU.
    Omura G; DiSaia P; Blessing J; Boronow R; Hreshchyshyn M; Park R
    Cancer Treat Rep; 1977 Nov; 61(8):1533-5. PubMed ID: 922756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I trial of ftorafur combined with mitomycin C or methyl-CCNU in gastrointestinal cancers.
    Buroker T; Baker L; Correa J; Schwartz LA; Vailtkevicius VK
    Cancer Treat Rep; 1977; 61(3):463-7. PubMed ID: 326403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination chemotherapy with CCNU, melphalan, methotrexate, and prednisone (CAMP) in 35 patients with advanced breast cancer.
    Hansen M; Palshof T; Osterlind K; Hansen HH; Mouridsen H
    Cancer Treat Rep; 1977 Nov; 61(8):1603-5. PubMed ID: 922762
    [No Abstract]   [Full Text] [Related]  

  • 14. Methyl-CCNU (NSCU-95441) versus methyl-CCNU plus cyclophosphamide (NSC-26271) in advanced gastrointestinal cancer.
    Rossi A; Riva A; Bonadonna G
    Cancer Chemother Rep; 1975; 59(6):1161-2. PubMed ID: 769958
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapy of advanced gastrointestinal cancer with the nitrosoureas.
    Moertel CG
    Cancer Chemother Rep 3; 1973 May; 4(3):27-34. PubMed ID: 4748872
    [No Abstract]   [Full Text] [Related]  

  • 16. 5-fluorouracil versus CCNU in the treatment of metastatic prostatic cancer.
    Tejada F; Eisenberger MA; Broder LA; Cohen MH; Simon R
    Cancer Treat Rep; 1977 Nov; 61(8):1589-90. PubMed ID: 922761
    [No Abstract]   [Full Text] [Related]  

  • 17. Adriamycin and CCNU in the treatment of advanced breast cancer.
    Muss HB; White DR; Richards F; Cooper MR; Spurr CL
    Cancer Treat Rep; 1976 Nov; 60(11):1687-9. PubMed ID: 1021240
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemotherapy of gynecologic cancer with nitrosoureas: a randomized trial of CCNU and methyl-CCNU in cancers of the cervix, corpus, vagina, and vulva.
    Omura GA; Shingleton HM; Creasman WT; Blessing JA; Boronow RC
    Cancer Treat Rep; 1978 May; 62(5):833-5. PubMed ID: 350400
    [No Abstract]   [Full Text] [Related]  

  • 19. The nitrosoureas: carmustine (BCNU) and lomustine (CCNU).
    Weiss RB; Issell BF
    Cancer Treat Rev; 1982 Dec; 9(4):313-30. PubMed ID: 6762924
    [No Abstract]   [Full Text] [Related]  

  • 20. Trial of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) in advanced bronchogenic carcinoma 1,2,3.
    Stolinsky DC; Bull FE; Pajak TF; Bateman JR
    Oncology; 1975; 31(5-6):288-92. PubMed ID: 174040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.